Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process.
Journal: Developmental cell
Published: December 08, 2024
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.
Journal: Cancer research
Published: October 21, 2024
Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth.
Journal: Nature cell biology
Published: June 04, 2024
The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
Journal: Molecular oncology
Published: February 03, 2023
Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.
Journal: Neuron
Published: March 25, 2022
The biology of ependymomas and emerging novel therapies.
Journal: Nature reviews. Cancer
Published: December 01, 2021
How to live with a meningioma: experiences, symptoms, and challenges reported by patients.
Journal: Neuro-oncology advances
Published: August 15, 2020
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
Journal: Cell
Published: September 27, 2019
Medulloblastoma in the age of molecular subgroups: a review.
Journal: Journal of neurosurgery. Pediatrics
Published: May 14, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.
Journal: Nature
Published: August 13, 2018
Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Journal: Nature
Published: June 20, 2018
Medulloblastoma in the Molecular Era.
Journal: Journal of Korean Neurosurgical Society
Published: February 01, 2018
Last Updated: 09/26/2026